Literature DB >> 11189822

Sharing of drug preparation equipment as a risk factor for hepatitis C.

H Hagan1, H Thiede, N S Weiss, S G Hopkins, J S Duchin, E R Alexander.   

Abstract

OBJECTIVES: This study investigated the sharing of drug preparation equipment as a possible route of hepatitis C virus (HCV) transmission.
METHODS: HCV seroconversion was measured in a cohort of 317 injection drug users who tested negative for HCV antibody at recruitment.
RESULTS: Cumulative HCV incidence was 16.7% per year. Among those who did not share syringes, HCV seroconversion was associated with sharing drug cookers and filtration cotton (adjusted risk ratio = 5.9; 95% confidence interval = 1.1, 31.7); 54% of HCV infections in injection drug users who did not share syringes were attributable to cooker/cotton sharing.
CONCLUSIONS: Among injection drug users who do not share syringes, an important proportion of HCV infections may be attributed to cooker/cotton sharing.

Entities:  

Mesh:

Year:  2001        PMID: 11189822      PMCID: PMC1446500          DOI: 10.2105/ajph.91.1.42

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  25 in total

1.  Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey.

Authors:  A R Weild; O N Gill; D Bennett; S J Livingstone; J V Parry; L Curran
Journal:  Commun Dis Public Health       Date:  2000-06

2.  High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus.

Authors:  J I Esteban; J C López-Talavera; J Genescà; P Madoz; L Viladomiu; E Muñiz; C Martin-Vega; M Rosell; H Allende; X Vidal
Journal:  Ann Intern Med       Date:  1991-09-15       Impact factor: 25.391

3.  Response and follow-up bias in cohort studies.

Authors:  S Greenland
Journal:  Am J Epidemiol       Date:  1977-09       Impact factor: 4.897

4.  Prevalence, incidence, and risk factors of hepatitis C virus infection among drug users in Amsterdam.

Authors:  J A van den Hoek; H J van Haastrecht; J Goudsmit; F de Wolf; R A Coutinho
Journal:  J Infect Dis       Date:  1990-10       Impact factor: 5.226

5.  Attributable risk percent in case-control studies.

Authors:  P Cole; B MacMahon
Journal:  Br J Prev Soc Med       Date:  1971-11

6.  Acute hepatitis B infection in England and Wales: 1985-96.

Authors:  M A Balogun; M E Ramsay; C K Fairley; M Collins; J Heptonstall
Journal:  Epidemiol Infect       Date:  1999-02       Impact factor: 2.451

Review 7.  The first and second decades of AIDS among injecting drug users.

Authors:  D C Des Jarlais
Journal:  Br J Addict       Date:  1992-03

8.  Hepatitis C virus antibody prevalence among injecting drug users in Glasgow has fallen but remains high.

Authors:  D Goldberg; S Cameron; J McMenamin
Journal:  Commun Dis Public Health       Date:  1998-06

9.  Syringe exchange and risk of infection with hepatitis B and C viruses.

Authors:  H Hagan; J P McGough; H Thiede; N S Weiss; S Hopkins; E R Alexander
Journal:  Am J Epidemiol       Date:  1999-02-01       Impact factor: 4.897

10.  Prevalence and incidence of hepatitis C virus infection among young adult injection drug users.

Authors:  R S Garfein; M C Doherty; E R Monterroso; D L Thomas; K E Nelson; D Vlahov
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998
View more
  153 in total

1.  Hepatitis C among drug users: déjà vu all over again?

Authors:  D C Des Jarlais; A Schuchat
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

2.  Is it justifiable to withhold treatment for hepatitis C from illicit-drug users?

Authors:  B R Edlin; K H Seal; J Lorvick; A H Kral; D H Ciccarone; L D Moore; B Lo
Journal:  N Engl J Med       Date:  2001-07-19       Impact factor: 91.245

3.  Changes in injection risk behavior associated with participation in the Seattle needle-exchange program.

Authors:  H Hagan; H Thiede
Journal:  J Urban Health       Date:  2000-09       Impact factor: 3.671

Review 4.  Meta-analysis of hepatitis C seroconversion in relation to shared syringes and drug preparation equipment.

Authors:  Enrique R Pouget; Holly Hagan; Don C Des Jarlais
Journal:  Addiction       Date:  2012-04-17       Impact factor: 6.526

5.  Case-reporting of acute hepatitis B and C among injection drug users.

Authors:  Holly Hagan; Nadine Snyder; Eileen Hough; Tianji Yu; Shelly McKeirnan; Janice Boase; Jeffrey Duchin
Journal:  J Urban Health       Date:  2002-12       Impact factor: 3.671

6.  Explaining the geographical variation of HIV among injection drug users in the United States.

Authors:  D Ciccarone; P Bourgois
Journal:  Subst Use Misuse       Date:  2003-12       Impact factor: 2.164

7.  Safer injecting facilities in Vancouver: considering issues beyond potential use.

Authors:  Craig L Fry
Journal:  CMAJ       Date:  2003-10-14       Impact factor: 8.262

Review 8.  Updating the infection risk reduction hierarchy: preventing transition into injection.

Authors:  David Vlahov; Crystal M Fuller; Danielle C Ompad; Sandro Galea; Don C Des Jarlais
Journal:  J Urban Health       Date:  2004-03       Impact factor: 3.671

Review 9.  The provision of non-needle/syringe drug injecting paraphernalia in the primary prevention of HCV among IDU: a systematic review.

Authors:  Michelle Gillies; Norah Palmateer; Sharon Hutchinson; Syed Ahmed; Avril Taylor; David Goldberg
Journal:  BMC Public Health       Date:  2010-11-23       Impact factor: 3.295

10.  Survival of hepatitis C virus in syringes: implication for transmission among injection drug users.

Authors:  Elijah Paintsil; Huijie He; Christopher Peters; Brett D Lindenbach; Robert Heimer
Journal:  J Infect Dis       Date:  2010-10-01       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.